How Should US FDA Navigate Thorny First Amendment Conundrums: Former Chief Counsels Offer Advice
Executive Summary
Daniel Troy suggests FDA increase its investment in science of consumer understanding, while Richard Cooper recommends the "bully pulpit" approach to get industry's attention. A panel of former chief counsels stressed that the agency cannot continue to ignore First Amendment free speech issues.